ARTICLE | Clinical News
Biopool, Cosmo Bio Co. Ltd. regulatory update
July 14, 1997 7:00 AM UTC
Four of BIPL’s monoclonal antibody-based reagents were approved for sale in Japan. The reagents are part of BIPL’s immunohematology product line. Cosmo Bio, a division of Cosmo Oil Group (Tokyo, Japan...